Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study - Aix-Marseille Université Access content directly
Journal Articles Intensive Care Medicine Year : 2020

Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

Liesbet de Bus
  • Function : Author
Pieter Depuydt
  • Function : Author
Johan Steen
  • Function : Author
Sofie Dhaese
  • Function : Author
Ken de Smet
  • Function : Author
Murat Akova
  • Function : Author
Menino Osbert Cotta
  • Function : Author
Gennaro de Pascale
  • Function : Author
Shigeki Fujitani
  • Function : Author
Jose Garnacho-Montero
  • Function : Author
Marlies Ostermann
  • Function : Author
Jason Roberts
Farid Zand
  • Function : Author
Kapil Zirpe
  • Function : Author

Abstract

The DIANA study aimed to evaluate how often antimicrobial de-escalation (ADE) of empirical treatment is performed in the intensive care unit (ICU) and to estimate the effect of ADE on clinical cure on day 7 following treatment initiation.
Fichier principal
Vignette du fichier
134_2020_Article_6111.pdf (914.55 Ko) Télécharger le fichier
Origin : Publication funded by an institution
Licence : CC BY NC - Attribution - NonCommercial

Dates and versions

hal-02869005 , version 1 (12-10-2023)

Licence

Attribution

Identifiers

Cite

Liesbet de Bus, Pieter Depuydt, Johan Steen, Sofie Dhaese, Ken de Smet, et al.. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Medicine, 2020, ⟨10.1007/s00134-020-06111-5⟩. ⟨hal-02869005⟩
31 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More